TrialBMC medicine2005

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].

Heart Protection Study Collaborative GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.